معرفی
Jackob Moskovitz serves as an Associate Professor in the Department of Pharmacology & Toxicology at the University of Kansas School of Pharmacy. His research program focuses on understanding the molecular mechanisms of oxidative stress in aging and neurodegenerative diseases, with particular emphasis on the methionine sulfoxide reductase (Msr) system. Dr. Moskovitz maintains an active laboratory investigating how methionine oxidation affects protein function and contributes to age-related pathologies.
His educational background includes a D.Sc. from the Unit of Biochemistry at The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology (1992), followed by postdoctoral training at the National Heart, Lung, and Blood Institute, National Institutes of Health (2003), and at the Roche Institute of Molecular Biology (2003).
Dr. Moskovitz's research interests center on oxidative damage to proteins as a major contributor to aging and age-related diseases. His laboratory specifically investigates how methionine oxidation affects proteins like β-amyloid and α-synuclein in neurodegenerative conditions including Alzheimer's and Parkinson's diseases. The Msr system (comprising MsrA and MsrB enzymes) that reverses methionine oxidation represents a key focus of his work, with implications for understanding cellular antioxidant defenses and potential therapeutic interventions. His team employs molecular biology techniques and proteomic approaches using both ex-vivo and in vivo systems to determine the role of oxidative damage/repair in neurodegeneration.
Analysis of Dr. Moskovitz's recent publications reveals a strong focus on the connection between protein methionine oxidation and neurodegenerative disease pathology. His work spans from basic biochemical characterization of the Msr system to clinical correlations showing how protein-methionine sulfoxide levels in plasma correlate with Alzheimer's disease progression. The research demonstrates consistent exploration of how oxidative modifications affect protein function, particularly in neurological contexts, with implications for both understanding disease mechanisms and developing potential biomarkers or interventions.
Dr. Moskovitz has mentored several graduate students who have gone on to positions at institutions including the University of Iowa and pharmaceutical companies like Merck Inc. and Boehringer Ingelheim. His laboratory has produced significant findings regarding the MsrA knockout mouse model, which exhibits neurological disorders, increased sensitivity to oxidative stress, and reduced lifespan.
The Moskovitz Lab, located in Malott Hall at the University of Kansas, utilizes advanced molecular and biochemical approaches to investigate protein oxidation mechanisms. While not currently accepting new students or postdoctoral fellows, the lab has established important connections between methionine oxidation, protein dysfunction, and neurodegenerative disease progression.
